No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Europe and MEA Respiratory Panel Testing Market Report 2022-2031: Key Trends, Dynamics & Players

Editor: What To Know

  • These indices serve as valuable tools for existing market players as well as for entities interested in participating in the respiratory panel testing market in Europe and Middle East &.
  • Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the respiratory panel testing market in Europe and Middle East &.
  • Additionally, the report sheds light on the changing competitive dynamics in the respiratory panel testing market in Europe and Middle East &.

The “Respiratory Panel Testing Market – Europe and Middle East & Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031″ report has been added to ResearchAndMarkets.com’s offering.

This report on the respiratory panel testing market in Europe and Middle East & Africa studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the respiratory panel testing market in Europe and Middle East & Africa for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the respiratory panel testing market in Europe and Middle East & Africa for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the respiratory panel testing market in Europe and Middle East & Africa.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the respiratory panel testing market in Europe and Middle East & Africa.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the respiratory panel testing market in Europe and Middle East & Africa.

These indices serve as valuable tools for existing market players as well as for entities interested in participating in the respiratory panel testing market in Europe and Middle East & Africa. The next section of the respiratory panel testing market report highlights the USPs, which includes, COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), and key industry events (mergers, acquisitions, partnerships, etc.) across Europe and Middle East & Africa.

The report delves into the competitive landscape of the respiratory panel testing market in Europe and Middle East & Africa. Key players operating in the respiratory panel testing market in Europe and Middle East & Africa have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the respiratory panel testing market in report.

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Europe and Middle East & Africa Respiratory Panel Testing Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe and Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast, 2018-2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, etc.)

6. Europe and Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast, by Specimen Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Europe and Middle East & Africa Respiratory Panel Testing Market Value (US$ Mn) Forecast, by Specimen Type, 2017-2031
6.3.1. Viruses
6.3.2. Bacteria
6.4. Europe and Middle East & Africa Respiratory Panel Testing Market Attractiveness Analysis, by Specimen Type

7. Europe and Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast, by Panel Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Europe and Middle East & Africa Respiratory Panel Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
7.3.1. Syndromic Full Multiplex Panel
7.3.2. Low Plex Panel
7.4. Europe and Middle East & Africa Respiratory Panel Testing Market Attractiveness Analysis, by Panel Type

8. Europe and Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Europe and Middle East & Africa Respiratory Panel Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

9. Europe and Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Europe and Middle East & Africa Respiratory Panel Testing Market Value (US$ Mn) Forecast, by Region
9.2.1. Europe
9.2.2. Middle East & Africa
9.3. Europe and Middle East & Africa Respiratory Panel Testing Market Attractiveness Analysis, by Country/Region

10. Europe Respiratory Panel Testing Market Analysis and Forecast

11. Middle East & Africa Respiratory Panel Testing Market Analysis and Forecast

12. Competitive Landscape

 Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • bioMerieux SA
  • Medline Industries, Inc.
  • Becton, Dickinson & Company
  • altona Diagnostics GmbH
  • CerTest Biotec S.L.
  • Anatolia Geneworks
  • Seegene, Inc.
  • DiaSorin S.p.A. (Luminex)
  • QIAGEN
  • Biocartis

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy